Kenya Rejects U.S.-Funded Ebola Lab Amid Public Fury

Protesters took to the streets of Nairobi on Tuesday after the Kenyan government proposed a U.S.-funded Ebola testing and research facility in the capital. The Ministry of Health announced the project would involve a biosafety laboratory funded by Washington, with joint oversight between Nairobi and U.S. health authorities. Within 48 hours, objections from residents, parliamentarians, and advocacy groups forced officials to pause the initiative and announce a 60-day public consultation period.

What the facility would do

The proposed laboratory would handle advanced pathogen research and serve as a regional outbreak response hub for East Africa. U.S. agencies including the Centers for Disease Control and Prevention had committed an initial $45 million toward construction and staffing. Plans indicated the site would operate under a bilateral agreement granting American scientists access to Kenya's disease surveillance networks.

Health Secretary Susan Nakhumicha told reporters the facility was designed to strengthen Kenya's capacity to detect and contain Ebola strains before they spread beyond the region. "This is not an experiment on Kenyan citizens," she said during a press briefing in Nairobi. "It is a partnership built on mutual scientific benefit and public health protection."

Why protests erupted

Residents near the proposed site in the Kasarani district, roughly 10 kilometers from central Nairobi, objected to what they called a lack of meaningful community input. Protest organizers distributed leaflets listing concerns about potential contamination risks and the absence of a full environmental impact assessment. Multiple opposition politicians called for the project to be relocated to a less populated area.

The Kenyan chapter of the Kenya Medical Research Institute, a state body, issued a statement supporting the project but urged the government to clarify data-sharing arrangements with Washington. "Any facility of this sensitivity requires full transparency about who controls the samples and where they can be taken," said Dr. Isabella Okoth, a senior researcher at the institute.

The U.S. response

The American embassy in Nairobi confirmed it had offered technical assistance for the laboratory's design but said final decisions rested with Kenyan authorities. A State Department spokesperson said U.S. agencies had followed standard protocols for international health infrastructure projects. Washington has pursued similar biosecurity partnerships in recent years with Rwanda and Tanzania.

Kenya's Ebola history

Kenya sits on a major air travel corridor connecting West Africa to Asia and Europe, making it a high-risk point for imported cases. The country recorded no confirmed Ebola infections during the West African epidemic of 2014–2016, which killed more than 11,300 people, but health officials at the time acknowledged the system was ill-prepared for a large outbreak. Kenya later established a national task force for hemorrhagic fevers, which has since managed separate outbreaks of cholera and Rift Valley fever.

What comes next

Parliament's health committee will hold public hearings in Nairobi and Mombasa before making any recommendations to the executive branch. Committee chair Dr. James Mwangi told a local television station that MPs would not rubber-stamp the project and warned that foreign-funded research facilities must meet Kenya's own regulatory standards.

Watch for a formal environmental impact report expected within three weeks. That document will determine whether the site location changes or whether the project moves forward with revised oversight structures. Whatever decision emerges will likely shape how other East African nations negotiate similar disease-surveillance partnerships with foreign governments.